EnvMed is a nonprofit organisation engaged in establishing Environmental Medicine.
Given the increasing amount of harmful chemicals in the environment and the growing scientific evidence of correlations with chronic diseases, we are committed to reduce environmental exposures, promoting research into health links and treatments, better aligning medical care with these findings, and facilitating patient access to analysis.
1 July 2026 marks the full entry into force of the revised EU Mercury Regulation, completing the phase-out of dental amalgam across all European Union Member States. At the same time, new restrictions on the import and manufacture of dental amalgam have taken effect, representing a major milestone for public health, environmental protection, and the global transition toward mercury-free healthcare…
From 28 May 2026, manufacturers are required to register medical devices covered by certificates under the Medical Devices Regulation (EU) 2017/745 (MDR) in the European Database on Medical Devices (EUDAMED).
Mandatory EUDAMED registration will provide regulators, market operators, and stakeholders with a much clearer picture of the European dental amalgam market — including which manufacturers are active, which products are certified, and whether regulatory obligations are being met.
Uruguay has officially prohibited the use of dental amalgam through Ordenanza N° 285/026, marking a major milestone in reducing mercury exposure. The Minister of Public Health, Cristina Lustemberg, followed through on her commitment—introducing the ban just 2 weeks after the WHO regional workshop on the gradual reduction of dental amalgam held in Montevideo.
On Thursday, 19 March 2026 (13:00–14:30 CET), WHO will host the global launch of its new guideline: Environmentally friendly and less invasive oral health care for preventing and managing dental caries. The guideline provides evidence-based recommendations to support countries in preventing and managing dental caries through environmentally sustainable and less invasive approaches that promote patient safety, quality of care and environmental protection…
A hard-won political declaration on noncommunicable diseases, supported by the vast majority of UN member states, failed to be formally adopted during the high-level meeting of the General Assembly. The United States blocked its adoption by consensus so that the draft, which recognises the harm from chemicals, was referred back to the General Assembly where it passed on 15 December 2025.
The African Regional Centers of the Basel and Stockholm Convention supported the Children’s Amendment of the Minamata Convention by organising webinars in cooperation with the World Alliance for Mercury-Free Dentistry. The Children’s Amendments entered into force on 28 September 2023 and requires Parties to take action to protect Children from the use of dental amalgam..
Experiences from European countries demonstrate successful pathways for the transition to mercury-free oral health care. As effective and affordable alternatives are available, the primary challenge remains, to establish financial arrangements with dentists to provide aesthetic fillings in public programs. It should be borne in mind that dental amalgam is far more expensive than most, if not all, alternative materials when the high environmental costs are taken into account…
Global Overview of Countries Phasing Out Dental Amalgam: According to the Minamata Conventions Full National Reports 2021, the MIAs, or other official documents, the global transition to a mercury-free dentistry is fully underway…
Six of the seven leading amalgam manufacturers in 2020 have withdrawn from the market—either ceasing production or announcing plans to do so in the near future—while smaller companies have taken over the shrinking market…
In den chemiepolitischen Mittagstalks 2025 widmen wir uns der Frage, wie Chemikalien in der Umwelt wirken, wo sie überall nachweisbar sind und welche Konsequenzen das für Mensch und Natur hat. Wir blicken auf verschiedene Umweltmedien und Organismen, beleuchten aktuelle Forschungsergebnisse und diskutieren politische Handlungsmöglichkeiten. Zum vollständigen Programm…
NGOs fordern den Bundeskanzler auf, sich für die Regulierung von PFAS in der Europäischen Union auszusprechen. Die sogenannten „Ewigkeitschemikalien“ werden in zahlreichen Verbraucherprodukten, zum Beispiel in Kochpfannen oder Kosmetika, eingesetzt, aber auch in vielen Industrieprozessen und in Pestiziden werden sie genutzt.
Zivilgesellschaftliches Positionspapier: Per- und polyfluorierte Alkylsubstanzen (PFAS) sind eine Gruppe von über 10.000 chemischen Substanzen, die u. a. wegen ihrer Stabilität und wasser-, öl- und schmutzabweisenden Wirkungen in sehr vielen Bereichen verwendet werden. Aufgrund ihrer Stabilität werden sie in der Umwelt nicht abgebaut (“Ewigkeitschemikalien”) und können über sehr lange Zeiträume hinweg Umwelt- und Gesundheitsschäden hervorrufen.
The health impact of chemicals in the environment is constantly increasing. There is a significant associated rise in neurological, autoimmune and cancer diseases. Male fertility decreases dramatically. However, when patients visit the doctor, hardly any examinations are carried out for possible chemical exposures.
We bring researchers and practitioners in the fields of chemical biology, environmental medicine and medical geology together to showcase the recent developments and address global challenges we face today within the field of chemical toxicology and immunology.
Our mission is to advocate and support the adoption and implementation of legally binding instruments which contain mandatory obligations to eliminate where feasible, and otherwise minimize, the global use of hazardous chemicals, the global demand for hazardous chemicals, releases of hazardous chemicals to the environment, and human and wildlife exposure to hazardous chemicals.
The European Network for Environmental Medicine is a non-profit organisation located in Berlin. Your direct donations enable us to work on reducing environmental exposures, promoting research into health links and treatments, better aligning medical care with these findings, and facilitating patient access to analysis.